In the high-stakes game of gene therapy, adeno-associated virus (AAV) vectors have been the go-to workhorses. These vectors have the ability to deliver a therapeutic gene to a patient’s cells, offering hope for the treatment of genetic disorders, such as Duchenne muscular dystrophy, hemophilia A, and certain retinal degeneration disorders. But, akin to a mail […]
Tag: capsid
Advancing Gene Therapy with Latus Bio’s AAV Platform
Title: “Pioneering a New Era: Latus Bio’s AAV Technology Revolutionizes Gene Therapy Delivery” With an exciting blend of technological innovation and biological research, Latus Bio is challenging the status quo and promising an intriguing future for gene therapy. The company is capitalizing on the potential of adeno-associated viruses (AAVs) to cure genetic disorders such as […]
Innovative AAV Capsid Variant for Huntington’s & Parkinson’s Gene Therapy
In the dynamic world of biotechnology, few announcements are as exciting as the unveiling of a novel gene therapy approach. Latus Bio, a pioneering biotech firm, has done just that with the revelation of their groundbreaking research on a new variant of the Adeno-associated virus (AAV) capsid. This innovative variant has been meticulously designed to […]